Claus P. Behrens

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Randomized phase II trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in patients with metastatic castration-resistant prostate cancer: the CheckPRO, CA209-8TY trial.

Randomized phase II trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in patients with metastatic castration-resistant prostate cancer: the CheckPRO, CA209-8TY trial.

Journal: Journal for immunotherapy of cancer

Published: June 29, 2026

Dosimetric impact of esophageal motion in esophagus-sparing radiotherapy of spinal metastases.

Dosimetric impact of esophageal motion in esophagus-sparing radiotherapy of spinal metastases.

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 01, 2025

Predictors of acute and late diarrhea in the treatment of anal cancer with concurrent chemoradiotherapy.

Predictors of acute and late diarrhea in the treatment of anal cancer with concurrent chemoradiotherapy.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 30, 2025

Esophagus-sparing radiotherapy for complicated spinal metastases (ESO-SPARE). A randomized phase III clinical trial.

Esophagus-sparing radiotherapy for complicated spinal metastases (ESO-SPARE). A randomized phase III clinical trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 13, 2025

1-year efficacy results after MR-guided risk-adapted stereotactic radiotherapy of infra-diaphragmatic oligometastases in a multicenter phase II trial.

1-year efficacy results after MR-guided risk-adapted stereotactic radiotherapy of infra-diaphragmatic oligometastases in a multicenter phase II trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: September 29, 2024

Artificial intelligence-generated targets and inter-observer variation in online adaptive radiotherapy of bladder cancer.

Artificial intelligence-generated targets and inter-observer variation in online adaptive radiotherapy of bladder cancer.

Journal: Physics and imaging in radiation oncology

Published: May 24, 2024

Impact of geometric correction on echo-planar imaging-based apparent diffusion coefficient maps for abdominal radiotherapy.

Impact of geometric correction on echo-planar imaging-based apparent diffusion coefficient maps for abdominal radiotherapy.

Journal: Biomedical physics & engineering express

Published: April 18, 2024

Stereotactic Ablative Radiation Therapy of Bone Metastases in an Oligometastatic Setting: One-Year Follow-Up of the BONY-M Phase 2 Trial.

Stereotactic Ablative Radiation Therapy of Bone Metastases in an Oligometastatic Setting: One-Year Follow-Up of the BONY-M Phase 2 Trial.

Journal: International journal of radiation oncology, biology, physics

Published: January 28, 2024

Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study.

Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 24, 2024

New technologies from bench to bedside - report from the Nordic association for clinical physics 2023 symposium.

New technologies from bench to bedside - report from the Nordic association for clinical physics 2023 symposium.

Journal: Acta oncologica (Stockholm, Sweden)

Published: November 02, 2023

ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol.

ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol.

Journal: BMC cancer

Published: October 30, 2023

MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters.

MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 21, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026